Health & Wellness Personalis Inc share price jumps 50% on deals with Merck and Moderna These developments are a validation of Personalis' business strategy and its potential in the genomics and cancer treatment space Joseph MortonDecember 19, 2024
Medical and Pharmaceutical Summit Therapeutics up 55% as lung cancer drug outperforms Merck’s Analysts have now given the company a much higher share target price too Rowan DunneSeptember 9, 2024
AI and Autonomy NetraMark demonstrates efficacy of AI to help with clinical trials AI analyzes huge amounts of data, finds patterns, and makes decisions on its own Joseph MortonMarch 11, 2024
Psychedelics International psychedelics market to reach US$8.3B by 2027: ReportLinker The market was valued at US$4.83B this year and will rise with a CAGR of 14.5 per cent Rowan DunneApril 24, 2023
AI and Autonomy The Mugglehead technology roundup: sleep technologies Here's a bird's eye view of the sleep technology industry. Joseph MortonAugust 17, 2022
Analysis Psychedelic therapeutics market to have steady growth: InsightAce Clinical psychedelic sector value anticipated to ascend significantly into 2028 Rowan DunneJuly 19, 2022